Antigenic relevance of F protein in chronic hepatitis C virus infection

Hepatology

Volumn 40, Issue 4, 2004, Pages 900-909

  Komurian Pradel, Florence ^a   Rajoharison, Alain ^a   Berland, Jean Luc ^a   Khouri, Valérie ^a   Perret, Magali ^a   Van Roosmalen, Mark ^b   Pol, Stanislas ^c   Negro, Francesco ^d   Paranhos Baccalà, Glaucia ^a  

^a BIOMÉRIEUX   (France)

^b bioMerieux   (Netherlands)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANTIBODY; CORE PROTEIN; PROTEIN F; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADULT; AGED; AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; SERUM;

ADULT; AGED; EPITOPES; FEMALE; FRAMESHIFT MUTATION; GENOTYPE; HEPACIVIRUS; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; SEROEPIDEMIOLOGIC STUDIES; VIRAL CORE PROTEINS;

EID: 4644284772     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20406     Document Type: Article

References (24)

1. Purcell R. The hepatitis C virus: overview. HEPATOLOGY 1997;26:11S-14S.
2. Reed KE, Rice CM. Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Curr Top Microbiol Immunol 2000;242:55-84.
3. Walewski JL, Keller TR, Stump DD, Branch AD. Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame. RNA 2001;7:710-721.
4. Xu Z, Choi J, Yen TS, Lu W, Strohecker A, Govindarajan S, et al. Synthesis of a novel hepatitis C virus protein by ribosomal frameshift. EMBO J 2001;20:3840-3848.
5. Varaklioti A, Vassilaki N, Georgopoulou U, Mavromara P. Alternate translation occurs within the core coding region of the hepatitis C viral genome. J Biol Chem 2002;277:17713-17721.
6. Vassilaki N, Mavromara P. Two alternative mechanisms are responsible for the synthesis of the HCV ARFP/F/core+1 protein. J Biol Chem 2003;278:40503- 40513.
7. Boulant S, Becchi M, Penin F, Lavergne JP. Unusual multiple recoding events leading to alternative forms of hepatitis C virus core protein from genotype 1b. J Biol Chem 2003;278:45785-45792.
8. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. HEPATOLOGY 1996;24:289-293.
9. Komurian-Pradel F, Paranhos-Baccala G, Sodoyer M, Chevallier P, Mandrand B, Lotteau V, et al. Quantitation of HCV RNA using real-time PCR and fluorimetry. J Virol Methods 2001;95:111-119.
10. Andre P, Komurian-Pradel F, Deforges S, Perret M, Berland JL, Sodoyer M, et al. Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. J Virol 2002;76:6919-6928.
11. Li JS, Tong SP, Vitvitski L, Lepot D, Trepo C. Two French genotypes of hepatitis C virus: homology of the predominant genotype with the prototype American strain. Gene 1991;105:167-172.
12. Jolivet-Reynaud C, Dalbon P, Viola F, Yvon S, Paranhos-Baccala G, Piga N, et al. HCV core immunodominant region analysis using mouse monoclonal antibodies and human sera: characterization of major epitopes useful for antigen detection. J Med Virol 1998;56:300-309.
13. Wilson MB, Nakane PK. The covalent coupling of proteins to periodate-oxidized sephadex: a new approach to immunoadsorbent preparation. J Immunol Methods 1976;12:171-181.
14. Barban V, Fraysse-Corgier S, Paranhos-Baccala G, Petit M, Manin C, Berard Y, et al. Identification of a human epitope in hepatitis C virus (HCV) core protein using a molecularly cloned antibody repertoire from a non-symptomatic, anti-HCV-positive patient. J Gen Virol 2000;81:461-469.
15. Xu Z, Choi J, Lu W, Ou JH. Hepatitis C virus f protein is a short-lived protein associated with the endoplasmic reticulum. J Virol 2003;77:1578-1583.
16. Ogata S, Nagano-Fujii M, Ku Y, Yoon S, Hotta H. Comparative sequence analysis of the core protein and its frameshift product, the F protein, of hepatitis C virus subtype 1b strains obtained from patients with and without hepatocellular carcinoma. J Clin Microbiol 2002;40:3625-3630.
17. Yeh CT, Lo SY, Dai DI, Tang JH, Chu CM, Liaw YF. Amino acid substitutions in codons 9-11 of hepatitis C virus core protein lead to the synthesis of a short core protein product. J Gastroenterol Hepatol 2000;15:182-191.
18. Choi J, Xu Z, Ou JH. Triple decoding of hepatitis C virus RNA by programmed translational frameshifting. Mol Cell Biol 2003;23:1489-1497.
19. Roussel J, Pillez A, Montpellier C, Duverlie G, Cahour A, Dubuisson J, et al. Characterization of the expression of the hepatitis C virus F protein. J Gen Virol 2003;84:1751-1759.
20. McLauchlan J. Properties of the hepatitis C virus core protein: a structural protein that modulates cellular processes. J Viral Hepat 2000;7:2-14.
21. Moorman JP, Joo M, Hahn YS. Evasion of host immune surveillance by hepatitis C virus: potential roles in viral persistence. Arch Immunol Ther Exp (Warsz) 2001;49:189-194.
22. Moorman JP, Prayther D, McVay D, Hahn YS, Hahn CS. The C-terminal region of hepatitis C core protein is required for Fas-ligand independent apoptosis in Jurkat cells by facilitating Fas oligomerization. Virology 2003;312:320-329.
23. Large MK, Kittlesen DJ, Hahn YS. Suppression of host immune response by the core protein of hepatitis C virus: possible implications for hepatitis C virus persistence. J Immunol 1999;162:931-938.
24. Li D, Takyar ST, Lott WB, Gowans EJ. Amino acids 1-20 of the hepatitis C virus (HCV) core protein specifically inhibit HCV IRES-dependent translation in HepG2 cells, and inhibit both HCV IRES- and cap-dependent translation in HuH7 and CV-1 cells. J Gen Virol 2003;84:815-825.